title: Clinical significance of peripheral blood Epstein-Barr viral load monitoring using polymerase chain reaction in renal transplant recipients.
abstract: PTLD is a complication of EBV infection. We examined the efficacy of EBV-PCR monitoring to detect early replication in an attempt to prevent EBV-associated PTLD. Blood EBV levels in 156 renal transplant recipients (58 children) from three institutions over nine yr were retrospectively analyzed. Patients who were asymptomatic and at high risk for PTLD were monitored for EBV infection by PCR or serology followed by PCR at the time of EBV seropositivity. More children than adults had positive EBV-PCR (12/58 vs. 2/98, p < 0.001). Adults remained asymptomatic and viremia resolved post-therapy. 3/12 EBV-PCR positive children developed PTLD (3/12 children vs. 0/2 adults, p = NS). Two out of three with PTLD were initially monitored by serology, and later by PCR. PTLD resolved post-therapy in all three patients. The remaining 9/12 EBV-PCR positive children stayed asymptomatic. None of the children and adults with negative EBV-PCR developed PTLD. EBV-PCR monitoring in high-risk renal transplant recipients, especially in children, may allow early diagnosis and intervention, and therefore may help in preventing EBV-associated PTLD.
authors.affiliation: Transplant Immunology Laboratory, Ahmanson Pediatric Center, Steven Spielberg Pediatric Research Laboratories, Cedars-Sinai Medical Center/UCLA School of Medicine, Los Angeles, CA 90048, USA. Mieko.Toyoda@cshs.org
authors.forename: Mieko
authors.initials: M
authors.lastname: Toyoda
authors.forename: Asha
authors.initials: A
authors.lastname: Moudgil
authors.forename: Bradley A
authors.initials: BA
authors.lastname: Warady
authors.forename: Dechu P
authors.initials: DP
authors.lastname: Puliyanda
authors.forename: Stanley C
authors.initials: SC
authors.lastname: Jordan
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D020031:Epstein-Barr Virus Infections / Q000175:diagnosis* / Q000517:prevention & control; D004854:Herpesvirus 4, Human / Q000378:metabolism*; D006801:Humans; D016030:Kidney Transplantation / Q000379:methods*; D008232:Lymphoproliferative Disorders / Q000209:etiology / Q000517:prevention & control; D016133:Polymerase Chain Reaction / Q000379:methods; D012189:Retrospective Studies; D012306:Risk; D013997:Time Factors; D019562:Viral Load